| Product Code: ETC13385250 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Mumps Vaccine Market was valued at USD 1.3 Billion in 2024 and is expected to reach USD 1.8 Billion by 2031, growing at a compound annual growth rate of 6.10% during the forecast period (2025-2031).
The global mumps vaccine market is witnessing steady growth due to increasing awareness about preventive healthcare measures, government initiatives to control outbreaks, and a growing emphasis on immunization programs. Key players in the market are focusing on research and development activities to enhance vaccine efficacy and safety, as well as expanding their distribution networks to reach a wider customer base. The market is also benefiting from the rising prevalence of mumps infections, particularly in developing countries with limited access to healthcare facilities. Factors such as technological advancements in vaccine production and increasing investments in public health infrastructure are expected to further drive market growth. Overall, the global mumps vaccine market is projected to continue its expansion, fueled by the growing demand for effective immunization against mumps.
The Global Mumps Vaccine Market is experiencing growth due to increasing awareness about the importance of vaccination, especially in developing countries. The market is driven by the rising prevalence of mumps infections and outbreaks globally, leading to a higher demand for vaccines. Additionally, advancements in technology and research have led to the development of more effective and safer mumps vaccines, providing opportunities for market expansion. Furthermore, initiatives by governments and healthcare organizations to promote immunization programs are boosting the market growth. With a focus on preventive healthcare and the increasing adoption of vaccination as a public health measure, the Global Mumps Vaccine Market is expected to continue growing in the coming years, presenting promising opportunities for vaccine manufacturers and healthcare providers.
The Global Mumps Vaccine Market faces several challenges, including fluctuating demand due to periodic outbreaks of mumps in different regions, vaccine hesitancy among some populations leading to lower vaccination rates, and the presence of alternative vaccines in the market that offer combined protection against multiple diseases, making standalone mumps vaccines less attractive. Additionally, regulatory hurdles, high manufacturing costs, and the need for cold chain storage and distribution also pose challenges for market players. Developing more effective and long-lasting mumps vaccines, improving public awareness and education about the importance of vaccination, and addressing logistical issues in vaccine distribution are key areas that need to be addressed to overcome these challenges and drive growth in the Global Mumps Vaccine Market.
The Global Mumps Vaccine Market is primarily driven by the increasing awareness about the importance of vaccination in preventing mumps outbreaks and associated complications. Government initiatives promoting routine immunization programs, coupled with the rising prevalence of mumps infections worldwide, are key factors fueling market growth. Furthermore, the growing focus on healthcare infrastructure development in emerging economies, expanding vaccination coverage, and advancements in vaccine technology are driving the demand for mumps vaccines. Additionally, the surge in research and development activities aimed at developing more efficacious and safe vaccines, along with the collaborations between pharmaceutical companies and government agencies to enhance vaccination campaigns, are contributing to the expansion of the mumps vaccine market globally.
The government policies related to the Global Mumps Vaccine Market primarily revolve around the promotion of vaccination programs to ensure widespread immunization against mumps. Many governments around the world have implemented mandatory vaccination policies for children, especially as part of routine childhood immunization schedules. Governments also regulate the quality, safety, and efficacy of mumps vaccines through stringent approval processes conducted by regulatory authorities such as the FDA in the United States and the EMA in Europe. Additionally, government agencies often collaborate with international organizations like the World Health Organization (WHO) to coordinate efforts in mumps vaccine distribution, surveillance, and outbreak response to control the spread of mumps on a global scale.
The Global Mumps Vaccine Market is expected to witness steady growth in the coming years, driven by the increasing awareness about the importance of vaccination, government initiatives to control the spread of infectious diseases, and the growing focus on prevention rather than treatment. Factors such as the rising incidence of mumps outbreaks in various regions, especially in densely populated areas and among unvaccinated populations, will further fuel the demand for mumps vaccines. Additionally, advancements in vaccine technology, such as the development of more effective and safer vaccines, are likely to contribute to market expansion. Overall, the Global Mumps Vaccine Market is poised for growth as healthcare systems worldwide prioritize immunization programs to combat preventable diseases.
In the global mumps vaccine market, North America and Europe are the dominant regions due to higher awareness about the importance of vaccinations and strong healthcare infrastructure. Asia Pacific is also a significant market, driven by a large population base and increasing government initiatives to prevent infectious diseases. In the Middle East and Africa region, the market is expected to grow steadily as healthcare systems improve and awareness about vaccination increases. Latin America is experiencing moderate growth, with a rising focus on immunization programs and increasing investment in healthcare infrastructure. Overall, the mumps vaccine market is expected to witness steady growth across all regions, with varying levels of importance placed on vaccination programs and preventative healthcare measures.
Global Mumps Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Mumps Vaccine Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Mumps Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Global Mumps Vaccine Market - Industry Life Cycle |
3.4 Global Mumps Vaccine Market - Porter's Five Forces |
3.5 Global Mumps Vaccine Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Mumps Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.7 Global Mumps Vaccine Market Revenues & Volume Share, By Distribution channel, 2021 & 2031F |
4 Global Mumps Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Mumps Vaccine Market Trends |
6 Global Mumps Vaccine Market, 2021 - 2031 |
6.1 Global Mumps Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Mumps Vaccine Market, Revenues & Volume, By Pediatric, 2021 - 2031 |
6.1.3 Global Mumps Vaccine Market, Revenues & Volume, By Adult, 2021 - 2031 |
6.2 Global Mumps Vaccine Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Mumps Vaccine Market, Revenues & Volume, By Hospitals Pharmacies, 2021 - 2031 |
6.2.3 Global Mumps Vaccine Market, Revenues & Volume, By Drug Stores, 2021 - 2031 |
6.2.4 Global Mumps Vaccine Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Mumps Vaccine Market, Overview & Analysis |
7.1 North America Mumps Vaccine Market Revenues & Volume, 2021 - 2031 |
7.2 North America Mumps Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Mumps Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4 North America Mumps Vaccine Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
8 Latin America (LATAM) Mumps Vaccine Market, Overview & Analysis |
8.1 Latin America (LATAM) Mumps Vaccine Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Mumps Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Mumps Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
8.4 Latin America (LATAM) Mumps Vaccine Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
9 Asia Mumps Vaccine Market, Overview & Analysis |
9.1 Asia Mumps Vaccine Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Mumps Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Mumps Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
9.4 Asia Mumps Vaccine Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
10 Africa Mumps Vaccine Market, Overview & Analysis |
10.1 Africa Mumps Vaccine Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Mumps Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Mumps Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
10.4 Africa Mumps Vaccine Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
11 Europe Mumps Vaccine Market, Overview & Analysis |
11.1 Europe Mumps Vaccine Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Mumps Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Mumps Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
11.4 Europe Mumps Vaccine Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
12 Middle East Mumps Vaccine Market, Overview & Analysis |
12.1 Middle East Mumps Vaccine Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Mumps Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Mumps Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Mumps Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
12.4 Middle East Mumps Vaccine Market, Revenues & Volume, By Distribution channel, 2021 - 2031 |
13 Global Mumps Vaccine Market Key Performance Indicators |
14 Global Mumps Vaccine Market - Export/Import By Countries Assessment |
15 Global Mumps Vaccine Market - Opportunity Assessment |
15.1 Global Mumps Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Mumps Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
15.3 Global Mumps Vaccine Market Opportunity Assessment, By Distribution channel, 2021 & 2031F |
16 Global Mumps Vaccine Market - Competitive Landscape |
16.1 Global Mumps Vaccine Market Revenue Share, By Companies, 2024 |
16.2 Global Mumps Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here